Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) Director Luke Evnin sold 17,858 shares of the firm’s stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $1.08, for a total transaction of $19,286.64. Following the completion of the transaction, the director directly owned 2,890,128 shares […]

Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) Director Luke Evnin sold 28,009 shares of Werewolf Therapeutics stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $1.07, for a total transaction of $29,969.63. Following the completion of the transaction, the director owned 2,907,986 shares of […]